Dermata Therapeutics Inc (DRMA)
1.08
-0.04
(-3.58%)
USD |
NASDAQ |
Nov 18, 16:00
1.06
-0.02
(-1.85%)
Pre-Market: 08:26
Dermata Therapeutics Price: 1.08 for Nov. 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 18, 2024 | 1.11 | 1.11 | 1.050 | 1.08 | 49959.00 |
Nov 15, 2024 | 1.19 | 1.205 | 1.11 | 1.120 | 74602.00 |
Nov 14, 2024 | 1.23 | 1.29 | 1.15 | 1.189 | 60727.00 |
Nov 13, 2024 | 1.295 | 1.295 | 1.230 | 1.230 | 50283.00 |
Nov 12, 2024 | 1.38 | 1.38 | 1.25 | 1.29 | 45503.00 |
Nov 11, 2024 | 1.39 | 1.42 | 1.26 | 1.35 | 78172.00 |
Nov 08, 2024 | 1.32 | 1.540 | 1.32 | 1.385 | 216607.0 |
Nov 07, 2024 | 1.36 | 1.41 | 1.34 | 1.34 | 58238.00 |
Nov 06, 2024 | 1.30 | 1.420 | 1.29 | 1.35 | 87831.00 |
Nov 05, 2024 | 1.20 | 1.29 | 1.20 | 1.29 | 47707.00 |
Nov 04, 2024 | 1.25 | 1.25 | 1.20 | 1.218 | 31266.00 |
Nov 01, 2024 | 1.30 | 1.319 | 1.22 | 1.225 | 37771.00 |
Oct 31, 2024 | 1.31 | 1.38 | 1.25 | 1.27 | 97688.00 |
Oct 30, 2024 | 1.39 | 1.456 | 1.31 | 1.35 | 81064.00 |
Oct 29, 2024 | 1.42 | 1.478 | 1.38 | 1.39 | 34720.00 |
Oct 28, 2024 | 1.49 | 1.513 | 1.40 | 1.46 | 67215.00 |
Oct 25, 2024 | 1.40 | 1.55 | 1.36 | 1.49 | 235069.0 |
Oct 24, 2024 | 1.45 | 1.45 | 1.36 | 1.38 | 87813.00 |
Oct 23, 2024 | 1.61 | 1.617 | 1.43 | 1.45 | 89060.00 |
Oct 22, 2024 | 1.53 | 1.62 | 1.50 | 1.57 | 86308.00 |
Oct 21, 2024 | 1.51 | 1.63 | 1.51 | 1.56 | 137340.0 |
Oct 18, 2024 | 1.53 | 1.68 | 1.409 | 1.61 | 342508.0 |
Oct 17, 2024 | 1.31 | 1.59 | 1.31 | 1.58 | 1.785M |
Oct 16, 2024 | 1.30 | 1.50 | 1.30 | 1.33 | 276103.0 |
Oct 15, 2024 | 1.28 | 1.380 | 1.25 | 1.29 | 166394.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.08
Minimum
Nov 18 2024
1500.00
Maximum
Nov 03 2021
190.63
Average
32.78
Median
Price Benchmarks
NeuroBo Pharmaceuticals Inc | 2.31 |
Cognition Therapeutics Inc | 0.4627 |
ZyVersa Therapeutics Inc | 1.24 |
Bone Biologics Corp | 1.19 |
NovaBay Pharmaceuticals Inc | 0.6998 |
Price Related Metrics
Price to Book Value | 0.4283 |
Earnings Yield | -2.54K% |
Market Cap | 1.421M |